Published in Catheter Cardiovasc Interv on October 01, 2010
Percutaneous treatment of native aortic coarctation in adults. Neth Heart J (2011) 1.08
Imaging of thoracic aortic disease. Br J Radiol (2011) 0.84
Coarctation of the aorta - the current state of surgical and transcatheter therapies. Curr Cardiol Rev (2013) 0.82
Intravascular stent therapy for coarctation of the aorta. Methodist Debakey Cardiovasc J (2014) 0.81
Coarctation of the aorta: Management from infancy to adulthood. World J Cardiol (2015) 0.79
Endovascular treatment of acute type B dissection complicating aortic coarctation. Tex Heart Inst J (2013) 0.78
Complications of Aortic Stenting in Patients below 20 Years Old: Immediate and Intermediate Follow-Up. J Tehran Heart Cent (2011) 0.78
Aortic Coarctation Treated by PTA and Stenting: a Case Presentation and Literature Review. Maedica (Buchar) (2015) 0.75
One stage surgical treatment of aortic valve disease and aortic coarctation with aortic bypass grafting through the diaphragm and aortic valve replacement. J Cardiothorac Surg (2015) 0.75
Avoidable costs of stenting for aortic coarctation in the United Kingdom: an economic model. BMC Health Serv Res (2017) 0.75
Early and Midterm Results Following Interventional Coarctoplasty: Evaluation of Variables that Can Affect the Results. Korean Circ J (2016) 0.75
Radiation dose reduction in pediatric great vessel stent computed tomography using iterative reconstruction: A phantom study. PLoS One (2017) 0.75
Interventional cardiology in adults with congenital heart disease. Nat Rev Cardiol (2013) 0.75
Cardiovascular changes in children with coarctation of the aorta treated by endovascular stenting. J Hum Hypertens (2013) 0.75
Exercise Capacity Before and After Stent Placement for Coarctation of the Aorta: A Single-Center Case Series. Pediatr Cardiol (2017) 0.75
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol (2004) 5.44
Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv (2012) 3.32
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J (2010) 3.26
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol (2013) 2.97
Does the presence of accessory renal arteries affect the efficacy of renal denervation? JACC Cardiovasc Interv (2013) 2.90
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest (2010) 2.89
Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv (2011) 2.67
In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention (2011) 2.63
Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv (2013) 2.62
Paravalvular leak closure after transcatheter aortic valve replacement with a self-expanding prosthesis. Catheter Cardiovasc Interv (2013) 2.25
Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol (2005) 2.19
Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv (2010) 2.15
New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv (2009) 2.08
Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther (2005) 2.03
Renal denervation. Anadolu Kardiyol Derg (2014) 1.96
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90
Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J (2007) 1.89
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity (2012) 1.82
Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol (2013) 1.82
Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol (2008) 1.69
European Registry of Carotid Artery Stenting: results from a prospective registry of eight high volume EUROPEAN institutions. Catheter Cardiovasc Interv (2012) 1.61
Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc (2013) 1.59
One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther (2009) 1.53
The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol (2010) 1.51
Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. JACC Cardiovasc Interv (2012) 1.49
Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv (2011) 1.47
Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation. Catheter Cardiovasc Interv (2014) 1.47
Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv (2012) 1.46
Percutaneous femoral arteriovenous shunt creation for advanced chronic obstructive pulmonary disease: a single-center safety and efficacy study. Circ Cardiovasc Interv (2012) 1.46
A meta-analysis of proximal occlusion device outcomes in carotid artery stenting. Catheter Cardiovasc Interv (2012) 1.45
Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J (2013) 1.44
Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv (2012) 1.44
Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv (2003) 1.44
Complications of carotid stenting during live transmissions. JACC Cardiovasc Interv (2009) 1.42
Radiofrequency perforation and conventional needle percutaneous transseptal left heart access: pathological features. Catheter Cardiovasc Interv (2005) 1.42
Classification for carotid artery stenting complications: manifestation, management, and prevention. J Endovasc Ther (2010) 1.42
A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique. Catheter Cardiovasc Interv (2009) 1.40
Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol (2007) 1.40
Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol (2011) 1.39
Self-expanding stent implantation in arterial duct during hybrid palliation of hypoplastic left heart syndrome: midterm experience with a specially designed stent. EuroIntervention (2015) 1.39
A novel approach to treat residual peridevice leakage after left-atrial appendage closure. Catheter Cardiovasc Interv (2013) 1.38
Transseptal strategy in retrograde transcatheter valve-in-valve implantation for failed surgical aortic bioprosthesis. Catheter Cardiovasc Interv (2014) 1.38
Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study. J Endovasc Ther (2014) 1.37
Recurrent events after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv (2013) 1.37
European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention (2007) 1.36
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. EuroIntervention (2010) 1.34
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat (2010) 1.31
Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv (2007) 1.30
Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol (2012) 1.29
Renal denervation: tips and tricks to perform a technically successful procedure. EuroIntervention (2013) 1.28
Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv (2011) 1.23
Predictors of death and stroke after carotid angioplasty and stenting: a subgroup analysis of the Pro-CAS data. Stroke (2008) 1.18
Magnetic resonance-guided cardiac interventions using magnetic resonance-compatible devices: a preclinical study and first-in-man congenital interventions. Circ Cardiovasc Interv (2010) 1.16
Severe tricuspid valve stenosis secondary to pacemaker leads presenting as ascites and liver dysfunction: a complex problem requiring a multidisciplinary therapeutic approach. J Interv Card Electrophysiol (2008) 1.15
Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and shortterm results. J Heart Valve Dis (2007) 1.13
Intermediate follow-up following intravascular stenting for treatment of coarctation of the aorta. Catheter Cardiovasc Interv (2007) 1.13
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention (2016) 1.11
MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail (2012) 1.09
Atrioventricular block after transcatheter ASD closure using the Amplatzer septal occluder: risk factors and recommendations. Catheter Cardiovasc Interv (2010) 1.05
Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol (2005) 1.05
Singleton-merten syndrome and impaired cardiac function. J Am Coll Cardiol (2010) 1.04
Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention (2013) 1.03
Cardiac magnetic resonance imaging after stage I Norwood operation for hypoplastic left heart syndrome. Circulation (2005) 1.02
Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery. EuroIntervention (2013) 1.00
Fully percutaneous treatment of an aberrant right subclavian artery and thoracic aortic aneurysm. Vasc Med (2013) 0.97
Hybrid procedures: adverse events and procedural characteristics--results of a multi-institutional registry. Congenit Heart Dis (2010) 0.97
Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. J Am Coll Cardiol (2013) 0.97
Left atrial appendage closure using the Amulet device: an initial experience with the second generation amplatzer cardiac plug. Catheter Cardiovasc Interv (2014) 0.96
Delayed presentation of a post-traumatic left ventricular pseudoaneurysm in a child. Ann Thorac Surg (2010) 0.95
Percutaneous implantation of the left ventricular partitioning device for chronic heart failure: a pilot study with 1-year follow-up. Eur J Heart Fail (2010) 0.95
Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol (2008) 0.95
Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol (2008) 0.93
Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol (2013) 0.92
Illustration of the additional value of real-time 3-dimensional echocardiography to conventional transthoracic and transesophageal 2-dimensional echocardiography in imaging muscular ventricular septal defects: does this have any impact on individual patient treatment? J Am Soc Echocardiogr (2006) 0.92
Use of an implantable loop recorder in the evaluation of children with congenital heart disease. Am Heart J (2002) 0.92
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EuroIntervention (2015) 0.92
Transcatheter aortic valve implantation in patients with "porcelain" aorta (from a Multicenter Real World Registry). Am J Cardiol (2012) 0.92
Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry. Clin Res Cardiol (2012) 0.92
Stenting of a stenosed modified Blalock Taussig shunt after Norwood-I palliation for hypoplastic left heart. Heart (2007) 0.91
3D echocardiography for planning and guidance of interventional closure of VSD. JACC Cardiovasc Imaging (2013) 0.91
Multicentre experience with the BridgePoint devices to facilitate recanalisation of chronic total coronary occlusions through controlled subintimal re-entry. EuroIntervention (2011) 0.91
New concepts in transcatheter closure of paravalvular leaks. Future Cardiol (2008) 0.90
Renal denervation for hypertension. JACC Cardiovasc Interv (2012) 0.89
The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg (2013) 0.89
Percutaneous mitral valve repair with the MitraClip system according to the predicted risk by the logistic EuroSCORE: preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry. Catheter Cardiovasc Interv (2014) 0.88
Detection of carbon monoxide during routine anesthetics in infants and children. Anesth Analg (2010) 0.88
Carotid artery stenting versus surgery: adequate comparisons? Lancet Neurol (2010) 0.87
Iatrogenic aortopulmonary window after balloon dilation of left pulmonary artery stenosis following arterial switch operation. J Invasive Cardiol (2013) 0.87
Percutaneous injection of thrombin for the treatment of pseudoaneurysms: the German multicentre registry. EuroIntervention (2007) 0.87